Aditya Bagrodia, MD
Urology · San Diego, CANPI 1730310665
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $38,613 of the $49,336 with a category attached, or 78.3%. Ferring Pharmaceuticals Inc. accounts for 64.3% of it on its own, with 35 other manufacturers making up the rest. Among urology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $347.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$32K
- Urogen Pharma, Inc.$11K
- Johnson & Johnson$931
- AstraZeneca$877
- Medtronic$635
- Intuitive Surgical$620
- plus $4K from 30 others
Across 6 payments — averaging $4005.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Blue Earth Diagnostics$24K
What the payments were for
- Speaking & faculty fees$38,61378%
- Travel & lodging$3,0156%
- Food & beverage$7,69416%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 22 | $31,747 |
| Urogen Pharma, Inc. | 13 | $10,765 |
| Johnson & Johnson(2 entities) | 24 | $931 |
| AstraZeneca | 12 | $877 |
| Medtronic(2 entities) | 7 | $635 |
| Intuitive Surgical | 9 | $620 |
| Bayer | 1 | $442 |
| Photocure Inc | 4 | $345 |
| Teleflex LLC | 1 | $226 |
| Merck | 4 | $191 |
| Foundation Medicine, Inc. | 2 | $177 |
| Janssen Scientific Affairs, LLC | 3 | $173 |
| Conmed Corporation | 1 | $157 |
| Davol Inc. | 2 | $155 |
| Biotissue Holdings Inc. | 1 | $147 |
| Boston Scientific | 1 | $143 |
| Exelixis Inc. | 5 | $134 |
| Profound Medical Corp. | 3 | $129 |
| Sumitomo Pharma America, Inc. | 1 | $125 |
| Olympus America Inc. | 1 | $115 |
| Blue Earth Diagnostics | 3 | $115 |
| Ambu Inc. | 1 | $114 |
| Dendreon Pharmaceuticals LLC | 1 | $114 |
| Procept Biorobotics Corporation | 1 | $109 |
| KARL Storz Endoscopy-america | 1 | $88 |
| Histosonics, Inc. | 1 | $79 |
| Coloplast | 2 | $78 |
| EDAP Technomed Inc | 2 | $77 |
| Astellas Pharma US Inc | 1 | $72 |
| Eisai Inc. | 3 | $62 |
| Pfizer | 3 | $50 |
| Immunitybio, Inc. | 2 | $46 |
| Myriad Genetic Laboratories, Inc. | 1 | $36 |
| Novartis | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $21 |
| Antares Pharma, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADSTILADRIN$31,414
- ZUSDURI$6,188
- JELMYTO$4,277
- LYNPARZA$604
- Nubeqa$442
- INTERSTIM$391
- AIRSEAL$157
- VISTASEAL$154
- ECHELON FLEX Stapler$154
- Erleada$150
- NEOX$147
- CLARIX$147
- rezum Generator$143
- Cysview$126
- SURGICEL NU-KNIT$125
- ORGOVYX$125
- Olympus Cystoscopes$115
- PROVENGE$114
- ARISTA AH FLEXITIP$111
- AquaBeam Robotic System$109
How this compares
$49,336 in reported general payments places this provider in the 90th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 23 | $63,525 |
| MyrbetriqMirabegron | 26 | $14,959 |
| Tamsulosin Hcl | 81 | $1,593 |
| Finasteride | 41 | $658 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $46 |
| Ciprofloxacin Hcl | 28 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx | $125 | $63,52523 claims |
| Astellas Pharma US IncMyrbetriq | $72 | $14,95926 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,324 urology providers in California.
Other urology in San Diego
- Elward CrawfordSan Diego$849K
- Roger SurSan Diego$356K
- Emily ColeSan Diego$261K
- Seth BechisSan Diego$260K
- Tung-Chin HsiehSan Diego$240K
- Mark PeSan Diego$226K
- Irwin GoldsteinSan Diego$178K
- Manoj MongaSan Diego$154K
- Stephen FreedlandWest Hollywood$1.9M
- Arie BelldegrunLos Angeles$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.